Bio-rad Laboratories, Inc.(BIO)
$319.42▲1.35%
Market is closed - opens 7 PM, 29 Jul 2024
Insights
- Bio-rad Laboratories, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Bio-rad Laboratories, Inc. stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Bio-rad Laboratories, Inc. stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Bio-rad Laboratories, Inc. stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 64.2 | Sell |
Stochastic | 82.46, 75.09 | Neutral |
Ultimate Oscillator | 50.49 | Neutral |
Stochastic Relative Strength Index | 63.56, 60.55 | Neutral |
Moving Average Convergence Divergence | 7.25, 4.93 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 306.87 | Buy |
20 | 290.9 | Buy |
50 | 288.98 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 303.93 | Buy |
20 | 297.19 | Buy |
50 | 293.16 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 306.17 | Neutral |
20 | 289.93 | Buy |
50 | 288.49 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 311.94 | Buy |
20 | 306.02 | Buy |
50 | 290.17 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 313.34 | Buy |
20 | 312.46 | Buy |
50 | 298.49 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 320.12 |
Resistance L2 | 316.59 |
Resistance L1 | 313.25 |
Pivot Point | 309.72 |
Support L1 | 306.38 |
Support L2 | 302.85 |
Support L3 | 299.51 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.